BlackRock Inc. Makes New Investment in Acumen Pharmaceuticals, Inc. $ABOSMarket Beat·Sep 5 at 07:24 AMABOS-0.63%BLK-1.90%
Acumen Pharmaceuticals to Participate in Upcoming Investor ConferencesUnusual Whales·Sep 2 at 08:01 PMABOS-0.63%
Acumen Pharmaceuticals to present at Cantor Global Healthcare Conference fireside chatPUBT·Sep 2 at 08:00 PMABOS-0.63%C-0.71%
Acumen Pharmaceuticals (ABOS) Q2 2026 Earnings Call: ALTITUDE-AD Readout Due Late 2026TradingKey·Aug 14 at 08:04 AMABOS-0.63%
Acumen Pharmaceuticals posts corporate presentation on sabirnetug antibody program for early Alzheimer’s diseasePUBT·Aug 12 at 11:50 AMABOS-0.63%
Acumen Q2 FY26 net loss narrows to $32.7 million; R&D expenses fall to $27.8 millionPUBT·Aug 12 at 11:06 AMABOS-0.63%
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business HighlightsUnusual Whales·Aug 12 at 11:01 AMABOS-0.63%
Acumen Pharmaceuticals to report Q2 financial results, host conference callPUBT·Aug 5 at 08:00 PMABOS-0.63%
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026Unusual Whales·Jul 15 at 11:32 AMABOS-0.63%
